Skip to main content
MOA Life Plus Co. Ltd. logo

MOA Life Plus Co. Ltd. — Investor Relations & Filings

Ticker · 142760 ISIN · KR7142760008 KO Manufacturing
Open in API
Filings indexed 361 across all filing types
Latest filing 2025-12-29 Capital/Financing Update
Country KR South Korea
Listing KO 142760

About MOA Life Plus Co. Ltd.

http://moalifeplus.com/

MOA Life Plus Co. Ltd. is a biopharmaceutical company that researches and develops innovative medicines and consumer healthcare products. The company's pharmaceutical division focuses on a pipeline of biopharmaceuticals, including immunotherapies, cancer treatments, and vaccines for infectious diseases. A core platform technology utilizes Gamma-Polyglutamic Acid (γ-PGA), a natural amino acid polymer derived from fermented foods, to enhance immune responses and serve as a vaccine adjuvant. The consumer business division provides tailored healthcare solutions for immunity enhancement, skin rejuvenation, and pet care. It also manufactures and supplies γ-PGA-based raw materials for the cosmetics industry.

Recent filings

Filing Released Lang Actions
전환가액의조정
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing titled '전환가액의조정' (Adjustment of Conversion Price) for Moa Life Plus. It details the adjustment of the conversion price for convertible bonds (11th series), including the pre-adjustment price, post-adjustment price, the reason for the adjustment (market price increase), and the calculation methodology. This type of filing relates to changes in the company's capital structure and financial instruments, which falls under the 'Capital/Financing Update' category.
2025-12-29 Korean
[기재정정]소액공모공시서류(지분증권)
Regulatory Filings Classification · 95% confidence The document is a '소액공모공시서류(지분증권) 정정신고' (Small-scale Public Offering Disclosure Statement Amendment) filed by '주식회사 모아라이프플러스'. It details changes to the subscription and payment schedule for a capital increase (issuance of new shares). According to the provided definitions, this document is a regulatory filing related to capital changes and public offering disclosures. Since it is a formal regulatory filing submitted to the financial authorities (FSS/DART) and does not fit into more specific categories like '10-K' (Annual Report) or 'ER' (Earnings Release), it is classified as a Regulatory Filing.
2025-12-24 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding a decision on a capital increase (유상증자결정) by Moa Life Plus. It details the amendment of payment dates, share issuance terms, and third-party allocation details. In the context of Korean corporate filings, this is a standard regulatory disclosure regarding capital structure changes, which falls under the 'Share Issue/Capital Change' category.
2025-12-24 Korean
전환청구권행사
Share Issue/Capital Change Classification · 95% confidence The document is a formal regulatory filing regarding the exercise of conversion rights (전환청구권행사) for convertible bonds issued by Moa Life Plus. It details the number of shares to be issued, the conversion price, and the remaining balance of convertible bonds. This type of disclosure regarding capital structure changes and share issuance resulting from debt conversion falls under the 'Share Issue/Capital Change' category.
2025-12-24 Korean
[기재정정]주요사항보고서(자기전환사채매도결정)
Capital/Financing Update Classification · 95% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean financial authorities (Financial Services Commission/Korea Exchange). It specifically details the 'Decision to Sell Treasury Convertible Bonds' (자기전환사채매도결정) and is an amendment (정정신고) to a previous filing. This type of corporate action regarding the sale of treasury securities falls under capital structure and financing updates. Since it is a specific regulatory filing regarding a transaction of financial instruments, it is classified as a Capital/Financing Update.
2025-12-23 Korean
[기재정정]주요사항보고서(유상증자결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) specifically regarding a 'Decision on Paid-in Capital Increase' (유상증자결정). It details the amendment of payment dates and listing dates for a third-party allocation capital increase. This falls under the category of capital structure changes and financing activities, which is classified as 'CAP'.
2025-12-18 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.